SEVERANCE AND CHANGE OF CONTROL AGREEMENTSeverance and Change of Control Agreement • March 1st, 2021 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionCHANGE OF CONTROL AGREEMENT by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Daniel Soland (the "Executive"), dated as of February 19, 2021.
SEVERANCE AND CHANGE OF CONTROL AGREEMENTSeverance and Change of Control Agreement • May 4th, 2017 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 4th, 2017 Company Industry JurisdictionCHANGE OF CONTROL AGREEMENT by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and < Name> (the "Executive"), dated as of <Date>.